Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon announced that it received FDA breakthrough device designation for its microwave ablation technology. The transbronchial microwave ablation technology, which is currently under development, utilizes robotic-assisted bronchoscopy. Johnson & Johnson’s acquisitions of NeuWave Medical and Auris Health allowed the company to bring the robotic surgical and microwave ablation technology together to […]
NeuWave Medical Inc.
Auris Health, previously known as Auris Surgical Robotics, said today it inked a cooperative development and commercialization deal with Johnson & Johnson (NYSE:JNJ) division Ethicon’s NeuWave Medical subsidiary looking to develop systems for the robotically-assisted bronchoscopic ablation of lung lesions. Through the agreement, both companies will help develop an integrated system for robotic control, navigation and […]
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it closed its purchase of soft-tissue microwave ablation system maker NeuWave Medical for an undisclosed amount. NeuWave Medical’s ablation technology was developed at the University of Wisconson, Ethicon said. The company’s Certus 140 ablation system allows for single or simultaneous multiple probe procedures in patients with soft tissue lesions. “Currently, there are […]
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it is buying soft tissue microwave ablation system producer NeuWave Medical for an undisclosed amount. NeuWave Medical’s ablation technology was developed at the University of Wisconson, Ethicon said. The company’s Certus 140 ablation system allows for single or simultaneous multiple probe procedures in patients with soft tissue lesions. […]
NeuWave Medical said today it won FDA premarket approval for its Ablation Confirmation software, which will be integrated into its Intelligent Ablation system. The new system uses computed tomography which allows physicians to visualize and confirm ablation targets and lesions using images from CT scanners, according to the company. The computer-contolled ablation system also has greater […]
UPDATED May 28, 2015, with details on investors, comment from management.
NeuWave Medical – developer of a microwave ablation tumor removal tool – pulled in more than $25.3 million in a Series C round led by Versant Ventures.
Wisconsin medical device maker NeuWave Medical is more than halfway to wrapping up a hoped-for $19 million equity funding round, with $14 million in the bank so far and 22 accredited investors, according to an SEC filing.
The new filing offered more details on a fundraising round that began almost 1 year ago. As of yesterday, the ablation device company has about $5 million left to go to top off the fund-raise.
Four medical device companies reeled in more than $70 million in recent weeks, to develop technologies including a laser scalpel for minimally invasive surgeries, a peripheral vessel stapler, a thermal ablation system and a biliary stent.
Cambridge, Mass.-based OmniGuide led the charge with a $35 million round from Orbimed Advisors. OmniGuide chairman Yoel Fink told MassDevice.com in 2010 that the device uses the mirror technology he pioneered at the Mass. Institute of Technology in the 1990s.
Here’s a roundup of the latest dealflow and investment news: